Page 67 - Magyar Gasztroenterológiai Társaság 2020. november 6–7. – ONLINE KONGRESSZUS
P. 67

Előadáskivonatok / Abstracts


             started for 8/46(17.4%) patients. Deviation from guidelines in   1.  Institute  for  Translational  Medicine,  Szentágothai
             both  IVF  therapy  and  feeding  recommendations  did  not   Research  Centre,  Medical  School,  University  of  Pécs,
             deteriorate  the  course  of  APP  (p=0.297),  but  significantly   Hungary; 2. Division of Gastroenterology, First Department
             increased the length of hospitalization(LOH) (14.8±5.6 days   of  Medicine,  Medical  School,  University  of  Pécs,  Pécs,
             vs  26.2±4.4  days,  p=0.034).  Half  of  the  patients  received   Hungary; 3. Szent György University Teaching Hospital of
             antibiotic therapy(AB). There were no difference in severity   Fejér  County,  Székesfehérvár,  Hungary;  4.  Institute  of
             between  patients  who  received  AB  for  prevention  (14/23,   Bioanalysis,  Medical  School,  University  of  Pécs,  Pécs,
             30%)  and  either  those  who  were  treated  with  AB  for   Hungary;  5.  1st  Department  of  Medicine,  University  of
             infection(9/23,  39.1%,p=0.64)  or  those  who  did  not  get   Szeged,  Szeged,  Hungary;  6.  County  Emergency  Clinical
             AB(23/46,  50%,p=0.65).  Preventive  AB  treatment  was   Hospital  Târgu  Mures;  George  Emil  Palade  University  of
             associated with significantly longer LOH.        Medicine,  Pharmacy,  Sciences  and  Technology  of  Târgu
             Conclusion: The results highlight that the evidence-based   Mureș,  Romania;  7.  Department  of  Internal  Medicine,
             EPC/HPSG guidelines should be followed strictly in order to   Division  of  Gastroenterology,  University  of  Debrecen,
             reduce the length of hospitalization in APP.     Debrecen, Hungary; 8. Dr. Bugyi István Hospital, Szentes,
                                                              Hungary; 9. Bajcsy-Zsilinszky Hospital, Budapest, Hungary;
             85. FIRST COMMON BILE DUCT STONE REMOVAL BY      10.  Heim  Pál  National  Institute  for  Pediatrics,  Budapest,
             SPYGLASS       GUIDED       ELECTROHYDRAULIC     Hungary;  11.  Centre  for  Translational  Medicine,  1st
             LITHOTRIPSY (EHL) IN HUNGARY                     Department  of  Medicine,  University  of  Szeged,  Szeged,
                                           1
                            1
                                                  1
                                     2
                    1
             Liebe R. , Molnár E. , Czakó L. , Tari K. , Bíró P. , Mészáros   Hungary;  12.  Division  of  Translational  Medicine,  First
               1
                           1
                                    1
             B. , Ácsné Tóth A. , Kovács I. , Rácz S. , Sahin P.    Department of Medicine, Medical School, University of Pécs,
                                                    1
                                            1
             1. Department of Gastroenterology, Jahn Ferenc Dél-pesti   Pécs,  Hungary;  13.  Hungarian  Academy  of  Sciences  -
             Hospital, Budapest, Hungary; 2. 1st Department of Internal   University  of  Szeged,  Momentum  Gastroenterology
             Medicine, University of Szeged, Szeged, Hungary   Multidisciplinary Research Group, Szeged, Hungary; 14. on
                                                              behalf of the Hungarian Pancreatic Study Group
             Introduction:  SpyGlass  Direct  Visualization  System  is  a
             single-operator  peroral  cholangioscopy  technique  that   Introduction:  Disturbance  of  consciousness  (DOC)  may
             provides direct visualization of biliary ducts. SpyGlass can be   develop in acute pancreatitis (AP). In clinical practice, it is
             used  for  both  diagnostic  and  therapeutic  purposes  in   known that DOC may worsen the patient’s condition.
             biliopancreatic  diseases.  Treatment  of  difficult  bile  duct   Aims:  There  is  no  exact  data  on  how  DOC  affects  the
             stones by SpyGlass guided EHL has not been attempted in   outcome of AP, our aim was to show associations between
             Hungary before.                                  DOC and AP.
                                                              Methods: From the Hungarian Pancreatic Study Groups’ AP
             Aims: Our aim is to present the first case of SpyGlass guided   registry,  1220  cases  contained  the  exact  data  on  DOC.
             EHL  in  Hungary  (with  video  demonstration)  and  to  draw   Patients  were  separated  to  Non-DOC  and  DOC,  whereas
             attention to its relevance in the treatment of bile duct stones.    DOC was further divided into non-alcohol related DOC (Non-
             Case description: We present the case of an 83-year-old   ALC DOC) and ALC-DOC groups. Statistical analysis was
             female  patient  who  had  previously  undergone  five  ERCP   performed by SPSS 24 Software Package.
             procedures due to multiple bile duct stones. Unfortunately,   Results:  From  the  1220  patients,  47  (3.85%)  developed
             the  stones  could  not  have  been  removed  by  conventional   DOC, 23 (48.9%) cases were ALC DOC vs. 24 (51.1%) Non-
             endoscopic  techniques  due  to  moderate  benign  distal   ALC  DOC.  The  incidence  of severe  AP  was  higher in the
             common bile duct stenosis. Therefore, we decided to remove   DOC compared to the Non-DOC group (19.15% vs. 5.29%,
             the  stones  by  SpyGlass  guided  EHL  for  the  first  time  in   p<0.001). The mortality was higher in the DOC vs. Non-DOC
             Hungary.  During  the  initial cholangiography, 5 stones  (10-  group   (14.89%   vs.   1.71%,   p<0.001).   Length   of
             14mm)  were  detected  in  the  common  bile  duct.  After   hospitalization (LOH) was longer in the DOC vs. non-DOC
             extracting some of the stones by mechanical lithotripsy, we   group  (Me:11;  IQR:8-17  days  vs.  Me:9;  IQR:6-13  days,
             achieved direct visualization of the remaining biliary stones   p=0.049). Patients with ALC DOC developed more frequently
             by SpyGlass system. We managed to target and break them   moderately-severe  AP  vs.  Non-ALC  DOC  (43.48%  vs.
             by  EHL,  then  stone  fragments  and  smaller  stones  were   12.5%), while the incidence of severe AP was significantly
             removed  by  balloon  and  Dormia  basket.  Post-procedural   higher in Non-ALC vs. ALC DOC group (33.33% vs. 4.35%)
             acute cholangitis was detected which is the most common   (p<0.001). LOH showed tendency to be longer in Non-ALC
             adverse event related to SpyGlass examinations. The patient   DOC compared to ALC DOC respectively (Me:13; IQR:7-20
             fully recovered.                                 days vs. Me:9.5; IQR:8-15.5 days, p=0.119).
                                                              Conclusion: DOC during AP is associated with a higher rate
             Conclusion: SpyGlass guided EHL is an effective treatment   of  moderate  and  severe  AP  and  increases  the  risk  of
             of difficult bile duct stones refractory to conventional therapy.   mortality;  therefore,  the  DOC  should  be  closely  monitored
             The  first  procedure  in  Hungary  was  successful,  however,   and prevented in AP
             further experience is needed.
                                                              87.  FREQUENCY  OF  SEVERE  COMPLICATIONS  IN
             86.    DISTURBANCE      OF     CONSCIOUSNESS     DIABETIC AND NON-DIABETIC CHRONIC HEPATITIS C
             DETERIORATES     THE   SEVERITY    OF   ACUTE    PATIENTS    USING   MATCHED-PAIR     ANALYSIS.
             PANCREATITIS.  AN  INTERNATIONAL  MULTICENTRE    RESULTS OF A COMPARATIVE STUDY FROM A NORTH-
             COHORT  ANALYSES  OF  1220  PROSPECTIVELY        EAST HUNGARIAN REGION
             COLLECTED PATIENTS                               Lombay B. , Szalay F.
                                                                      1
                                                                               2
             Lillik V. , Vincze Á. , Izbéki F. , Gajdán L. , Gódi S. , Illés A. ,   1. Department of Gastroenterology, Borsod County Central
                                                   2
                                   3
                                                          2
                                            3
                           2
                   1
             Sarlós  P. ,  Farkas  N. ,  Erőss  B. ,  Hágendorn  R. 1,11 , Illés   Teaching Hospital, Miskolc; 2. Clinic of Internal Medicine and
                                        1
                    2
                              1,4
             D. , Varjú P. , Márta K. , Török I. , Papp M. , Vitális Z. , Bod   Oncology, Semmelweis University, Budapest
                                              7
                               1
                                                       7
                                      6
                       1
               5
             B. , Hamvas J. , Szepes Z. , Takács T. , Czakó L. , Szentesi
                                           5
                        9
                                  5
               8
                                                   5
               1,5
             A. , Párniczky A. 1,10,11 , Hegyi P. 1,12,13,14 , Mikó A. 1,2,11
                                                                                                          65

                                                                Central European Journal of Gastroenterology and Hepatology   65
                                                                            Volume 6, Supplementum 2 / November 2020
   62   63   64   65   66   67   68   69   70   71   72